Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
Jubilant Cadista Pharmaceuticals, Inc.

Jubilant Cadista Pharmaceuticals, Inc. Recalls

All product recalls associated with Jubilant Cadista Pharmaceuticals, Inc..

Get alerts for this brand

Recall Summary

Total Recalls

1000

Past Year

303

Class I (Serious)

Most Recent

Nov 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 1281–1300 of 4747 recalls

Methylprednisolone Tablets (Jubilant Cadista) – Illegible Label (2021)

Labeling: Illegible label: Customer complaint received of mis-alignment print of the printed dosing instructions on the blister card.

Class IIILow

FDAFeb 19, 2021Nationwide• Jubilant Cadista Pharmaceuticals, Inc.

Daytrana 15mg (Noven) – Delivery System Defect (2021)

Defective Delivery System: Out of specification for mechanical peel.

Class IIModerate

FDAFeb 19, 2021Nationwide• Noven Pharmaceuticals Inc

Daytrana 10mg (Noven) – Delivery System Defect (2021)

Defective Delivery System: Out of specification for mechanical peel.

Class II

1...63 646566 67...238

Page 65 of 238Next

Moderate

FDAFeb 19, 2021Nationwide• Noven Pharmaceuticals Inc

Daytrana 30mg (Noven) – Delivery System Defect (2021)

Defective Delivery System: Out of specification for mechanical peel.

Class IIModerate

FDAFeb 19, 2021Nationwide• Noven Pharmaceuticals Inc

Daytrana 20mg (Noven) – Delivery System Defect (2021)

Defective Delivery System: Out of specification for mechanical peel.

Class IIModerate

FDAFeb 19, 2021Nationwide• Noven Pharmaceuticals Inc

Ortho-Clinical Diagnostics, Inc.: VITROS Chemistry Products Calibrator Kit 4-(Calibrator va...

Potential total iron-binding capacity (TIBC) results. The VITROS TIBC performance shift will start with the newest Generation (GEN) of VITROS Fe Slides (GEN 26), the potential shift in TIBC patient values of GEN 26 and above will be approximately 80 ug/dL lower across the measuring range than other available GENS of VITROS Fe Slides (GENs 22-25).

FDAFeb 18, 2021Nationwide• Ortho-Clinical Diagnostics, Inc.

Acyclovir Sodium 1000mg (Zydus) – Product Crystallization (2021)

Crystallization: customer complaints for crystallization in finished product.

Class IHigh

FDAFeb 18, 2021Nationwide• Zydus Pharmaceuticals (USA) Inc

Acyclovir Sodium 500mg (Zydus) – Product Crystallization (2021)

Crystallization: customer complaints for crystallization in finished product.

Class IHigh

FDAFeb 18, 2021Nationwide• Zydus Pharmaceuticals (USA) Inc

Metoclopramide Injection (Teva) – Chemical Contamination (2021)

Chemical contamination; Unknown brown residue adhering to the inside of one vial.

Class IIModerate

FDAFeb 15, 2021Nationwide• Teva Pharmaceuticals USA

Ortho-Clinical Diagnostics, Inc.: VITROS Immunodiagnostic Products SARS-CoV-2 Antigen Reage...

VITROS Immunodiagnostic Products SARS-CoV-2 Antigen False Reactive Results Associated When Using Remel M4RT Viral Transport Media

FDAFeb 12, 2021Nationwide• Ortho-Clinical Diagnostics, Inc.

Ortho-Clinical Diagnostics, Inc.: VITROS SARS-CoV-2 Antigen Reagent Pack - The VITROS Immun...

VITROS Immunodiagnostic Products SARS-CoV-2 Antigen False Reactive Results Associated When Using Remel M4RT Viral Transport Media

FDAFeb 12, 2021Nationwide• Ortho-Clinical Diagnostics, Inc.

Getinge Group Logistics America, LLC: Operating Table System

There is a potential for hydraulic leakage at the inclination function to occur resulting in an unintended Trendelenburg or anti-Trendelenburg movement of the table top depending on patient positioning which may lead to the patient having to be transferred to another OR table causing a delay in the procedure.

FDAFeb 11, 2021AL, AK, AZ +39 more• Getinge Group Logistics America, LLC

Metoclopramide Injection (Teva) – Sterility Risk (2021)

Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.

Class IIModerate

FDAFeb 10, 2021Nationwide• Teva Pharmaceuticals USA

Stay Informed

Jubilant Cadista Pharmaceuticals, Inc. Recalls

Recall Summary

Methylprednisolone Tablets (Jubilant Cadista) – Illegible Label (2021)

Daytrana 15mg (Noven) – Delivery System Defect (2021)

Daytrana 10mg (Noven) – Delivery System Defect (2021)

Daytrana 30mg (Noven) – Delivery System Defect (2021)

Daytrana 20mg (Noven) – Delivery System Defect (2021)

Ortho-Clinical Diagnostics, Inc.: VITROS Chemistry Products Calibrator Kit 4-(Calibrator va...

Acyclovir Sodium 1000mg (Zydus) – Product Crystallization (2021)

Acyclovir Sodium 500mg (Zydus) – Product Crystallization (2021)

Metoclopramide Injection (Teva) – Chemical Contamination (2021)

Ortho-Clinical Diagnostics, Inc.: VITROS Immunodiagnostic Products SARS-CoV-2 Antigen Reage...

Ortho-Clinical Diagnostics, Inc.: VITROS SARS-CoV-2 Antigen Reagent Pack - The VITROS Immun...

Getinge Group Logistics America, LLC: Operating Table System

Metoclopramide Injection (Teva) – Sterility Risk (2021)

Methylprednisolone Acetate (Teva) – Sterility Risk (2021)

Epoprostenol Sodium (Teva) – sterility risk (2021)

Vecuronium Bromide (Teva) – Sterility Risk (2021)

Leucovorin Calcium (Teva) – Sterility Risk (2021)

Methylprednisolone Acetate (Teva) – sterility risk (2021)

Methylprednisolone Acetate (Teva) – sterility risk (2021)

Epoprostenol Sodium (Teva) – sterility risk (2021)